Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I've been hearing similar rumblings. It's tough to get definitive information, but the talk about 'streamlining operations' seems to be a common theme. I'm hoping it's more about internal process improvements and less about significant headcount reductions, but the uncertainty is definitely unsettling for many.
The general industry landscape is certainly putting pressure on medtech companies. While I haven't seen anything official, it wouldn't be surprising if ZB is looking at ways to optimize their structure. Keep an eye on their investor relations page for any official announcements regarding their strategic direction.